Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19327
Title: Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Agents, Alkylating/administration & dosage/*adverse,effects/pharmacokinetics,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Male,Middle Aged,Monosaccharide Transport Proteins/biosynthesis/*metabolism,Neoplasms/drug therapy/*metabolism,Phosphoramide Mustards/administration & dosage/*adverse effects/pharmacokinetics
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19327
ISSN: 0732-183X
Link: http://www.ncbi.nlm.nih.gov/pubmed/11032596
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Briasoulis-2000-phase I trial.pdf241.05 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons